CommercialPrior AuthHigh impact
Genetic Testing Update
Blue Cross Blue Shield of Nebraska·NE · Genetics, Oncology, Hematology +5 more·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Blue Cross Blue Shield of Nebraska is implementing comprehensive genetic testing policy updates effective January 1, 2025, requiring preauthorization for all genetic testing procedures. The policy establishes specific medical necessity criteria for hereditary cancer panels, tumor analysis, and other genetic tests across multiple specialties.
Action Required
By January 1, 2025: Billing team must update systems to require preauthorization for all genetic testing codes listed in the policy. Update encounter forms and EMR templates to include specific medical necessity criteria for hereditary cancer panels, neuroendocrine testing, and HLA typing. Train providers on new criteria requirements as claims will be denied without proper documentation and preauthorization.